NEXT LIQUID BIOPSY

Welcome to the Brand page for “NEXT LIQUID BIOPSY”, which is offered here for Analysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment;liquid biopsy;providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development;.

Its status is currently believed to be active. Its class is unavailable. “NEXT LIQUID BIOPSY” is believed to be currently owned by “Personalis, Inc.”